nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluphenazine—HTR6—Raloxifene—osteoporosis	0.239	0.463	CbGbCtD
Fluphenazine—CYP1A2—Estropipate—osteoporosis	0.0758	0.147	CbGbCtD
Fluphenazine—ABCB1—Ethinyl Estradiol—osteoporosis	0.0427	0.0828	CbGbCtD
Fluphenazine—CYP1A2—Conjugated Estrogens—osteoporosis	0.0358	0.0695	CbGbCtD
Fluphenazine—CYP2D6—Cholecalciferol—osteoporosis	0.0322	0.0624	CbGbCtD
Fluphenazine—CYP1A2—Estradiol—osteoporosis	0.0315	0.061	CbGbCtD
Fluphenazine—ABCB1—Conjugated Estrogens—osteoporosis	0.0313	0.0608	CbGbCtD
Fluphenazine—ABCB1—Estradiol—osteoporosis	0.0275	0.0533	CbGbCtD
Fluphenazine—Menstruation irregular—Estradiol—osteoporosis	0.00209	0.00863	CcSEcCtD
Fluphenazine—Libido increased—Estradiol—osteoporosis	0.0019	0.00786	CcSEcCtD
Fluphenazine—Urine output increased—Calcitriol—osteoporosis	0.00185	0.00767	CcSEcCtD
Fluphenazine—Photosensitivity—Alendronate—osteoporosis	0.00178	0.00736	CcSEcCtD
Fluphenazine—Polyuria—Calcitriol—osteoporosis	0.0017	0.00701	CcSEcCtD
Fluphenazine—Tenderness—Conjugated Estrogens—osteoporosis	0.00165	0.00684	CcSEcCtD
Fluphenazine—Renal failure acute—Ibandronate—osteoporosis	0.00165	0.00681	CcSEcCtD
Fluphenazine—Jaundice cholestatic—Conjugated Estrogens—osteoporosis	0.00164	0.0068	CcSEcCtD
Fluphenazine—Anaphylactoid reaction—Estropipate—osteoporosis	0.00164	0.00678	CcSEcCtD
Fluphenazine—Asthma—Etidronic acid—osteoporosis	0.00158	0.00655	CcSEcCtD
Fluphenazine—Pancytopenia—Etidronic acid—osteoporosis	0.0015	0.00622	CcSEcCtD
Fluphenazine—Disturbance in sexual arousal—Calcitriol—osteoporosis	0.00148	0.00611	CcSEcCtD
Fluphenazine—Eczema—Ethinyl Estradiol—osteoporosis	0.00143	0.00592	CcSEcCtD
Fluphenazine—Asthma—Estropipate—osteoporosis	0.00137	0.00567	CcSEcCtD
Fluphenazine—Asthma—Alendronate—osteoporosis	0.00135	0.00558	CcSEcCtD
Fluphenazine—Dysphagia—Alendronate—osteoporosis	0.00135	0.00558	CcSEcCtD
Fluphenazine—Tenderness—Estradiol—osteoporosis	0.00132	0.00548	CcSEcCtD
Fluphenazine—Agranulocytosis—Etidronic acid—osteoporosis	0.00132	0.00545	CcSEcCtD
Fluphenazine—Jaundice cholestatic—Estradiol—osteoporosis	0.00131	0.00544	CcSEcCtD
Fluphenazine—Dysphagia—Ibandronate—osteoporosis	0.00131	0.00544	CcSEcCtD
Fluphenazine—Asthma—Ibandronate—osteoporosis	0.00131	0.00544	CcSEcCtD
Fluphenazine—Renal failure acute—Pamidronate—osteoporosis	0.00129	0.00534	CcSEcCtD
Fluphenazine—Hypertension—Ergocalciferol—osteoporosis	0.00128	0.0053	CcSEcCtD
Fluphenazine—Hypotension—Calcium Acetate—osteoporosis	0.00128	0.0053	CcSEcCtD
Fluphenazine—Disturbance in sexual arousal—Ethinyl Estradiol—osteoporosis	0.00128	0.00528	CcSEcCtD
Fluphenazine—Upper respiratory tract infection—Estropipate—osteoporosis	0.00127	0.00527	CcSEcCtD
Fluphenazine—Photosensitivity reaction—Alendronate—osteoporosis	0.00123	0.0051	CcSEcCtD
Fluphenazine—Anaphylactoid reaction—Pamidronate—osteoporosis	0.00123	0.00509	CcSEcCtD
Fluphenazine—Dyskinesia—Estradiol—osteoporosis	0.00123	0.00509	CcSEcCtD
Fluphenazine—Upper respiratory tract infection—Ibandronate—osteoporosis	0.00122	0.00505	CcSEcCtD
Fluphenazine—Lethargy—Pamidronate—osteoporosis	0.00122	0.00503	CcSEcCtD
Fluphenazine—Decreased appetite—Calcium Acetate—osteoporosis	0.00119	0.00493	CcSEcCtD
Fluphenazine—Pneumonia—Raloxifene—osteoporosis	0.00119	0.00493	CcSEcCtD
Fluphenazine—Pneumonia—Ibandronate—osteoporosis	0.00118	0.00488	CcSEcCtD
Fluphenazine—Renal failure acute—Zoledronate—osteoporosis	0.00118	0.00488	CcSEcCtD
Fluphenazine—Constipation—Calcium Acetate—osteoporosis	0.00117	0.00485	CcSEcCtD
Fluphenazine—Drowsiness—Calcitriol—osteoporosis	0.00115	0.00475	CcSEcCtD
Fluphenazine—Renal failure acute—Conjugated Estrogens—osteoporosis	0.00113	0.00469	CcSEcCtD
Fluphenazine—Lethargy—Zoledronate—osteoporosis	0.00111	0.00459	CcSEcCtD
Fluphenazine—Erythema—Etidronic acid—osteoporosis	0.0011	0.00457	CcSEcCtD
Fluphenazine—Asthma—Risedronate—osteoporosis	0.00108	0.00448	CcSEcCtD
Fluphenazine—Anaphylactoid reaction—Conjugated Estrogens—osteoporosis	0.00108	0.00448	CcSEcCtD
Fluphenazine—Oedema peripheral—Estropipate—osteoporosis	0.00108	0.00447	CcSEcCtD
Fluphenazine—Oedema peripheral—Alendronate—osteoporosis	0.00106	0.0044	CcSEcCtD
Fluphenazine—Muscle spasms—Etidronic acid—osteoporosis	0.00106	0.00439	CcSEcCtD
Fluphenazine—Decreased appetite—Ergocalciferol—osteoporosis	0.00105	0.00436	CcSEcCtD
Fluphenazine—Oedema peripheral—Raloxifene—osteoporosis	0.00105	0.00433	CcSEcCtD
Fluphenazine—Urine output increased—Estradiol—osteoporosis	0.00104	0.00432	CcSEcCtD
Fluphenazine—Constipation—Ergocalciferol—osteoporosis	0.00104	0.00429	CcSEcCtD
Fluphenazine—Oedema peripheral—Ibandronate—osteoporosis	0.00104	0.00429	CcSEcCtD
Fluphenazine—Gynaecomastia—Estradiol—osteoporosis	0.00103	0.00428	CcSEcCtD
Fluphenazine—Upper respiratory tract infection—Ethinyl Estradiol—osteoporosis	0.00103	0.00427	CcSEcCtD
Fluphenazine—Hypersensitivity—Calcium Acetate—osteoporosis	0.00101	0.00418	CcSEcCtD
Fluphenazine—Angioedema—Etidronic acid—osteoporosis	0.00101	0.00417	CcSEcCtD
Fluphenazine—Upper respiratory tract infection—Risedronate—osteoporosis	0.00101	0.00416	CcSEcCtD
Fluphenazine—Leukopenia—Etidronic acid—osteoporosis	0.000988	0.00409	CcSEcCtD
Fluphenazine—Pneumonia—Risedronate—osteoporosis	0.000971	0.00402	CcSEcCtD
Fluphenazine—Pruritus—Calcium Acetate—osteoporosis	0.000971	0.00402	CcSEcCtD
Fluphenazine—Upper respiratory tract infection—Pamidronate—osteoporosis	0.000957	0.00396	CcSEcCtD
Fluphenazine—Polyuria—Estradiol—osteoporosis	0.000955	0.00395	CcSEcCtD
Fluphenazine—Erythema—Estropipate—osteoporosis	0.000955	0.00395	CcSEcCtD
Fluphenazine—Erythema—Alendronate—osteoporosis	0.000941	0.00389	CcSEcCtD
Fluphenazine—Asthma—Zoledronate—osteoporosis	0.00094	0.00389	CcSEcCtD
Fluphenazine—Dysphagia—Zoledronate—osteoporosis	0.00094	0.00389	CcSEcCtD
Fluphenazine—Eczema—Estradiol—osteoporosis	0.000933	0.00386	CcSEcCtD
Fluphenazine—Pneumonia—Pamidronate—osteoporosis	0.000923	0.00382	CcSEcCtD
Fluphenazine—Nasal congestion—Estradiol—osteoporosis	0.00092	0.00381	CcSEcCtD
Fluphenazine—Muscle spasms—Estropipate—osteoporosis	0.000918	0.0038	CcSEcCtD
Fluphenazine—Erythema—Ibandronate—osteoporosis	0.000916	0.00379	CcSEcCtD
Fluphenazine—Asthma—Conjugated Estrogens—osteoporosis	0.000906	0.00375	CcSEcCtD
Fluphenazine—Dysphagia—Conjugated Estrogens—osteoporosis	0.000906	0.00375	CcSEcCtD
Fluphenazine—Muscle spasms—Alendronate—osteoporosis	0.000904	0.00374	CcSEcCtD
Fluphenazine—Erythema—Calcitriol—osteoporosis	0.000896	0.00371	CcSEcCtD
Fluphenazine—Pancytopenia—Zoledronate—osteoporosis	0.000893	0.00369	CcSEcCtD
Fluphenazine—Muscle spasms—Raloxifene—osteoporosis	0.000889	0.00368	CcSEcCtD
Fluphenazine—Muscle spasms—Ibandronate—osteoporosis	0.00088	0.00364	CcSEcCtD
Fluphenazine—Upper respiratory tract infection—Zoledronate—osteoporosis	0.000874	0.00362	CcSEcCtD
Fluphenazine—Angioedema—Estropipate—osteoporosis	0.000873	0.00361	CcSEcCtD
Fluphenazine—Anaphylactoid reaction—Estradiol—osteoporosis	0.000866	0.00358	CcSEcCtD
Fluphenazine—Angioedema—Alendronate—osteoporosis	0.000859	0.00356	CcSEcCtD
Fluphenazine—Agranulocytosis—Pamidronate—osteoporosis	0.000857	0.00354	CcSEcCtD
Fluphenazine—Lethargy—Estradiol—osteoporosis	0.000856	0.00354	CcSEcCtD
Fluphenazine—Oedema peripheral—Risedronate—osteoporosis	0.000854	0.00353	CcSEcCtD
Fluphenazine—Upper respiratory tract infection—Conjugated Estrogens—osteoporosis	0.000842	0.00348	CcSEcCtD
Fluphenazine—Angioedema—Ibandronate—osteoporosis	0.000837	0.00346	CcSEcCtD
Fluphenazine—Disturbance in sexual arousal—Estradiol—osteoporosis	0.000832	0.00344	CcSEcCtD
Fluphenazine—Agitation—Calcitriol—osteoporosis	0.000824	0.00341	CcSEcCtD
Fluphenazine—Nausea—Calcium Acetate—osteoporosis	0.000815	0.00337	CcSEcCtD
Fluphenazine—Hypertension—Ibandronate—osteoporosis	0.000791	0.00327	CcSEcCtD
Fluphenazine—Agranulocytosis—Zoledronate—osteoporosis	0.000783	0.00324	CcSEcCtD
Fluphenazine—Anaphylactic shock—Estropipate—osteoporosis	0.000779	0.00322	CcSEcCtD
Fluphenazine—Hypertension—Calcitriol—osteoporosis	0.000774	0.0032	CcSEcCtD
Fluphenazine—Constipation—Etidronic acid—osteoporosis	0.00077	0.00319	CcSEcCtD
Fluphenazine—Dry mouth—Ibandronate—osteoporosis	0.000762	0.00315	CcSEcCtD
Fluphenazine—Skin disorder—Estropipate—osteoporosis	0.000757	0.00313	CcSEcCtD
Fluphenazine—Anaphylactic shock—Ibandronate—osteoporosis	0.000747	0.00309	CcSEcCtD
Fluphenazine—Dry mouth—Calcitriol—osteoporosis	0.000746	0.00309	CcSEcCtD
Fluphenazine—Muscle spasms—Ethinyl Estradiol—osteoporosis	0.000744	0.00308	CcSEcCtD
Fluphenazine—Oedema peripheral—Zoledronate—osteoporosis	0.000742	0.00307	CcSEcCtD
Fluphenazine—Skin disorder—Raloxifene—osteoporosis	0.000733	0.00303	CcSEcCtD
Fluphenazine—Anaphylactic shock—Calcitriol—osteoporosis	0.000732	0.00303	CcSEcCtD
Fluphenazine—Skin disorder—Ibandronate—osteoporosis	0.000726	0.003	CcSEcCtD
Fluphenazine—Muscle spasms—Risedronate—osteoporosis	0.000726	0.003	CcSEcCtD
Fluphenazine—Asthma—Estradiol—osteoporosis	0.000725	0.003	CcSEcCtD
Fluphenazine—Dysphagia—Estradiol—osteoporosis	0.000725	0.003	CcSEcCtD
Fluphenazine—Nausea—Ergocalciferol—osteoporosis	0.00072	0.00298	CcSEcCtD
Fluphenazine—Erythema—Pamidronate—osteoporosis	0.000717	0.00297	CcSEcCtD
Fluphenazine—Urticaria—Etidronic acid—osteoporosis	0.000716	0.00296	CcSEcCtD
Fluphenazine—Oedema peripheral—Conjugated Estrogens—osteoporosis	0.000714	0.00295	CcSEcCtD
Fluphenazine—Skin disorder—Calcitriol—osteoporosis	0.000711	0.00294	CcSEcCtD
Fluphenazine—Angioedema—Ethinyl Estradiol—osteoporosis	0.000707	0.00293	CcSEcCtD
Fluphenazine—Somnolence—Estropipate—osteoporosis	0.000693	0.00287	CcSEcCtD
Fluphenazine—Muscle spasms—Pamidronate—osteoporosis	0.00069	0.00285	CcSEcCtD
Fluphenazine—Angioedema—Risedronate—osteoporosis	0.00069	0.00285	CcSEcCtD
Fluphenazine—Upper respiratory tract infection—Estradiol—osteoporosis	0.000674	0.00279	CcSEcCtD
Fluphenazine—Constipation—Estropipate—osteoporosis	0.000666	0.00276	CcSEcCtD
Fluphenazine—Hypersensitivity—Etidronic acid—osteoporosis	0.000664	0.00275	CcSEcCtD
Fluphenazine—Photosensitivity reaction—Estradiol—osteoporosis	0.000662	0.00274	CcSEcCtD
Fluphenazine—Agitation—Pamidronate—osteoporosis	0.000659	0.00273	CcSEcCtD
Fluphenazine—Constipation—Alendronate—osteoporosis	0.000656	0.00272	CcSEcCtD
Fluphenazine—Angioedema—Pamidronate—osteoporosis	0.000656	0.00271	CcSEcCtD
Fluphenazine—Erythema—Zoledronate—osteoporosis	0.000655	0.00271	CcSEcCtD
Fluphenazine—Hypertension—Risedronate—osteoporosis	0.000652	0.0027	CcSEcCtD
Fluphenazine—Somnolence—Calcitriol—osteoporosis	0.00065	0.00269	CcSEcCtD
Fluphenazine—Pneumonia—Estradiol—osteoporosis	0.00065	0.00269	CcSEcCtD
Fluphenazine—Decreased appetite—Ibandronate—osteoporosis	0.00065	0.00269	CcSEcCtD
Fluphenazine—Leukopenia—Pamidronate—osteoporosis	0.000642	0.00266	CcSEcCtD
Fluphenazine—Constipation—Ibandronate—osteoporosis	0.000639	0.00264	CcSEcCtD
Fluphenazine—Pruritus—Etidronic acid—osteoporosis	0.000637	0.00264	CcSEcCtD
Fluphenazine—Decreased appetite—Calcitriol—osteoporosis	0.000636	0.00263	CcSEcCtD
Fluphenazine—Erythema—Conjugated Estrogens—osteoporosis	0.000631	0.00261	CcSEcCtD
Fluphenazine—Muscle spasms—Zoledronate—osteoporosis	0.00063	0.00261	CcSEcCtD
Fluphenazine—Dry mouth—Risedronate—osteoporosis	0.000628	0.0026	CcSEcCtD
Fluphenazine—Constipation—Calcitriol—osteoporosis	0.000626	0.00259	CcSEcCtD
Fluphenazine—Hypertension—Pamidronate—osteoporosis	0.000619	0.00256	CcSEcCtD
Fluphenazine—Urticaria—Estropipate—osteoporosis	0.000619	0.00256	CcSEcCtD
Fluphenazine—Vision blurred—Zoledronate—osteoporosis	0.000618	0.00255	CcSEcCtD
Fluphenazine—Body temperature increased—Estropipate—osteoporosis	0.000616	0.00255	CcSEcCtD
Fluphenazine—Skin disorder—Ethinyl Estradiol—osteoporosis	0.000614	0.00254	CcSEcCtD
Fluphenazine—Urticaria—Alendronate—osteoporosis	0.00061	0.00252	CcSEcCtD
Fluphenazine—Body temperature increased—Alendronate—osteoporosis	0.000607	0.00251	CcSEcCtD
Fluphenazine—Muscle spasms—Conjugated Estrogens—osteoporosis	0.000607	0.00251	CcSEcCtD
Fluphenazine—Agitation—Zoledronate—osteoporosis	0.000602	0.00249	CcSEcCtD
Fluphenazine—Angioedema—Zoledronate—osteoporosis	0.000599	0.00248	CcSEcCtD
Fluphenazine—Skin disorder—Risedronate—osteoporosis	0.000598	0.00247	CcSEcCtD
Fluphenazine—Body temperature increased—Raloxifene—osteoporosis	0.000597	0.00247	CcSEcCtD
Fluphenazine—Vision blurred—Conjugated Estrogens—osteoporosis	0.000595	0.00246	CcSEcCtD
Fluphenazine—Urticaria—Ibandronate—osteoporosis	0.000594	0.00246	CcSEcCtD
Fluphenazine—Body temperature increased—Ibandronate—osteoporosis	0.000591	0.00244	CcSEcCtD
Fluphenazine—Leukopenia—Zoledronate—osteoporosis	0.000587	0.00243	CcSEcCtD
Fluphenazine—Anaphylactic shock—Pamidronate—osteoporosis	0.000585	0.00242	CcSEcCtD
Fluphenazine—Urticaria—Calcitriol—osteoporosis	0.000581	0.0024	CcSEcCtD
Fluphenazine—Body temperature increased—Calcitriol—osteoporosis	0.000578	0.00239	CcSEcCtD
Fluphenazine—Angioedema—Conjugated Estrogens—osteoporosis	0.000577	0.00239	CcSEcCtD
Fluphenazine—Hypersensitivity—Estropipate—osteoporosis	0.000574	0.00238	CcSEcCtD
Fluphenazine—Oedema peripheral—Estradiol—osteoporosis	0.000571	0.00236	CcSEcCtD
Fluphenazine—Tachycardia—Pamidronate—osteoporosis	0.000571	0.00236	CcSEcCtD
Fluphenazine—Hypertension—Zoledronate—osteoporosis	0.000566	0.00234	CcSEcCtD
Fluphenazine—Hypersensitivity—Alendronate—osteoporosis	0.000566	0.00234	CcSEcCtD
Fluphenazine—Headache—Etidronic acid—osteoporosis	0.000564	0.00233	CcSEcCtD
Fluphenazine—Pruritus—Estropipate—osteoporosis	0.000551	0.00228	CcSEcCtD
Fluphenazine—Hypersensitivity—Ibandronate—osteoporosis	0.000551	0.00228	CcSEcCtD
Fluphenazine—Dyspnoea—Risedronate—osteoporosis	0.000549	0.00227	CcSEcCtD
Fluphenazine—Hypotension—Pamidronate—osteoporosis	0.000547	0.00226	CcSEcCtD
Fluphenazine—Dry mouth—Zoledronate—osteoporosis	0.000546	0.00226	CcSEcCtD
Fluphenazine—Pruritus—Alendronate—osteoporosis	0.000543	0.00225	CcSEcCtD
Fluphenazine—Constipation—Ethinyl Estradiol—osteoporosis	0.00054	0.00223	CcSEcCtD
Fluphenazine—Hypersensitivity—Calcitriol—osteoporosis	0.000539	0.00223	CcSEcCtD
Fluphenazine—Nausea—Etidronic acid—osteoporosis	0.000535	0.00221	CcSEcCtD
Fluphenazine—Anaphylactic shock—Zoledronate—osteoporosis	0.000535	0.00221	CcSEcCtD
Fluphenazine—Pruritus—Ibandronate—osteoporosis	0.000529	0.00219	CcSEcCtD
Fluphenazine—Constipation—Risedronate—osteoporosis	0.000527	0.00218	CcSEcCtD
Fluphenazine—Dyspnoea—Pamidronate—osteoporosis	0.000522	0.00216	CcSEcCtD
Fluphenazine—Tachycardia—Zoledronate—osteoporosis	0.000522	0.00216	CcSEcCtD
Fluphenazine—Somnolence—Pamidronate—osteoporosis	0.000521	0.00215	CcSEcCtD
Fluphenazine—Skin disorder—Zoledronate—osteoporosis	0.000519	0.00215	CcSEcCtD
Fluphenazine—Pruritus—Calcitriol—osteoporosis	0.000518	0.00214	CcSEcCtD
Fluphenazine—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000515	0.00213	CcSEcCtD
Fluphenazine—Decreased appetite—Pamidronate—osteoporosis	0.000509	0.00211	CcSEcCtD
Fluphenazine—Erythema—Estradiol—osteoporosis	0.000505	0.00209	CcSEcCtD
Fluphenazine—Tachycardia—Conjugated Estrogens—osteoporosis	0.000503	0.00208	CcSEcCtD
Fluphenazine—Urticaria—Ethinyl Estradiol—osteoporosis	0.000502	0.00208	CcSEcCtD
Fluphenazine—Constipation—Pamidronate—osteoporosis	0.000501	0.00207	CcSEcCtD
Fluphenazine—Skin disorder—Conjugated Estrogens—osteoporosis	0.0005	0.00207	CcSEcCtD
Fluphenazine—Hypotension—Zoledronate—osteoporosis	0.0005	0.00207	CcSEcCtD
Fluphenazine—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000499	0.00207	CcSEcCtD
Fluphenazine—Urticaria—Risedronate—osteoporosis	0.000489	0.00202	CcSEcCtD
Fluphenazine—Headache—Estropipate—osteoporosis	0.000488	0.00202	CcSEcCtD
Fluphenazine—Body temperature increased—Risedronate—osteoporosis	0.000487	0.00201	CcSEcCtD
Fluphenazine—Muscle spasms—Estradiol—osteoporosis	0.000486	0.00201	CcSEcCtD
Fluphenazine—Hypotension—Conjugated Estrogens—osteoporosis	0.000481	0.00199	CcSEcCtD
Fluphenazine—Headache—Alendronate—osteoporosis	0.000481	0.00199	CcSEcCtD
Fluphenazine—Dyspnoea—Zoledronate—osteoporosis	0.000477	0.00197	CcSEcCtD
Fluphenazine—Somnolence—Zoledronate—osteoporosis	0.000475	0.00197	CcSEcCtD
Fluphenazine—Headache—Raloxifene—osteoporosis	0.000473	0.00196	CcSEcCtD
Fluphenazine—Headache—Ibandronate—osteoporosis	0.000468	0.00194	CcSEcCtD
Fluphenazine—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000465	0.00193	CcSEcCtD
Fluphenazine—Decreased appetite—Zoledronate—osteoporosis	0.000465	0.00192	CcSEcCtD
Fluphenazine—Agitation—Estradiol—osteoporosis	0.000464	0.00192	CcSEcCtD
Fluphenazine—Nausea—Estropipate—osteoporosis	0.000463	0.00192	CcSEcCtD
Fluphenazine—Body temperature increased—Pamidronate—osteoporosis	0.000463	0.00191	CcSEcCtD
Fluphenazine—Angioedema—Estradiol—osteoporosis	0.000461	0.00191	CcSEcCtD
Fluphenazine—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000459	0.0019	CcSEcCtD
Fluphenazine—Headache—Calcitriol—osteoporosis	0.000458	0.0019	CcSEcCtD
Fluphenazine—Somnolence—Conjugated Estrogens—osteoporosis	0.000458	0.00189	CcSEcCtD
Fluphenazine—Constipation—Zoledronate—osteoporosis	0.000457	0.00189	CcSEcCtD
Fluphenazine—Nausea—Alendronate—osteoporosis	0.000456	0.00189	CcSEcCtD
Fluphenazine—Hypersensitivity—Risedronate—osteoporosis	0.000454	0.00188	CcSEcCtD
Fluphenazine—Nausea—Raloxifene—osteoporosis	0.000448	0.00186	CcSEcCtD
Fluphenazine—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000448	0.00185	CcSEcCtD
Fluphenazine—Pruritus—Ethinyl Estradiol—osteoporosis	0.000447	0.00185	CcSEcCtD
Fluphenazine—Nausea—Ibandronate—osteoporosis	0.000444	0.00184	CcSEcCtD
Fluphenazine—Constipation—Conjugated Estrogens—osteoporosis	0.00044	0.00182	CcSEcCtD
Fluphenazine—Hypertension—Estradiol—osteoporosis	0.000436	0.0018	CcSEcCtD
Fluphenazine—Pruritus—Risedronate—osteoporosis	0.000436	0.0018	CcSEcCtD
Fluphenazine—Nausea—Calcitriol—osteoporosis	0.000435	0.0018	CcSEcCtD
Fluphenazine—Hypersensitivity—Pamidronate—osteoporosis	0.000431	0.00178	CcSEcCtD
Fluphenazine—Urticaria—Zoledronate—osteoporosis	0.000425	0.00176	CcSEcCtD
Fluphenazine—Body temperature increased—Zoledronate—osteoporosis	0.000423	0.00175	CcSEcCtD
Fluphenazine—Dry mouth—Estradiol—osteoporosis	0.00042	0.00174	CcSEcCtD
Fluphenazine—Pruritus—Pamidronate—osteoporosis	0.000414	0.00171	CcSEcCtD
Fluphenazine—Anaphylactic shock—Estradiol—osteoporosis	0.000412	0.00171	CcSEcCtD
Fluphenazine—Urticaria—Conjugated Estrogens—osteoporosis	0.000409	0.00169	CcSEcCtD
Fluphenazine—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000407	0.00168	CcSEcCtD
Fluphenazine—Tachycardia—Estradiol—osteoporosis	0.000402	0.00166	CcSEcCtD
Fluphenazine—Skin disorder—Estradiol—osteoporosis	0.0004	0.00166	CcSEcCtD
Fluphenazine—Headache—Ethinyl Estradiol—osteoporosis	0.000396	0.00164	CcSEcCtD
Fluphenazine—Hypersensitivity—Zoledronate—osteoporosis	0.000394	0.00163	CcSEcCtD
Fluphenazine—Headache—Risedronate—osteoporosis	0.000386	0.0016	CcSEcCtD
Fluphenazine—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000379	0.00157	CcSEcCtD
Fluphenazine—Pruritus—Zoledronate—osteoporosis	0.000378	0.00157	CcSEcCtD
Fluphenazine—Nausea—Ethinyl Estradiol—osteoporosis	0.000375	0.00155	CcSEcCtD
Fluphenazine—Dyspnoea—Estradiol—osteoporosis	0.000367	0.00152	CcSEcCtD
Fluphenazine—Headache—Pamidronate—osteoporosis	0.000367	0.00152	CcSEcCtD
Fluphenazine—Somnolence—Estradiol—osteoporosis	0.000366	0.00152	CcSEcCtD
Fluphenazine—Nausea—Risedronate—osteoporosis	0.000366	0.00151	CcSEcCtD
Fluphenazine—Pruritus—Conjugated Estrogens—osteoporosis	0.000364	0.00151	CcSEcCtD
Fluphenazine—Decreased appetite—Estradiol—osteoporosis	0.000358	0.00148	CcSEcCtD
Fluphenazine—Constipation—Estradiol—osteoporosis	0.000352	0.00146	CcSEcCtD
Fluphenazine—Nausea—Pamidronate—osteoporosis	0.000348	0.00144	CcSEcCtD
Fluphenazine—Headache—Zoledronate—osteoporosis	0.000335	0.00139	CcSEcCtD
Fluphenazine—Urticaria—Estradiol—osteoporosis	0.000327	0.00135	CcSEcCtD
Fluphenazine—Body temperature increased—Estradiol—osteoporosis	0.000326	0.00135	CcSEcCtD
Fluphenazine—Headache—Conjugated Estrogens—osteoporosis	0.000323	0.00133	CcSEcCtD
Fluphenazine—Nausea—Zoledronate—osteoporosis	0.000318	0.00131	CcSEcCtD
Fluphenazine—Nausea—Conjugated Estrogens—osteoporosis	0.000306	0.00127	CcSEcCtD
Fluphenazine—Hypersensitivity—Estradiol—osteoporosis	0.000304	0.00126	CcSEcCtD
Fluphenazine—Pruritus—Estradiol—osteoporosis	0.000292	0.00121	CcSEcCtD
Fluphenazine—Headache—Estradiol—osteoporosis	0.000258	0.00107	CcSEcCtD
Fluphenazine—Nausea—Estradiol—osteoporosis	0.000245	0.00101	CcSEcCtD
Fluphenazine—DRD3—Signaling Pathways—IRS2—osteoporosis	1.84e-05	7.56e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—KL—osteoporosis	1.83e-05	7.56e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—ADCY5—osteoporosis	1.83e-05	7.53e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—LEP—osteoporosis	1.82e-05	7.5e-05	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—ENO1—osteoporosis	1.82e-05	7.5e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—ADCY5—osteoporosis	1.82e-05	7.5e-05	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—POMC—osteoporosis	1.82e-05	7.49e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—ADCY5—osteoporosis	1.81e-05	7.46e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—ADCY5—osteoporosis	1.81e-05	7.46e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Hemostasis—TGFB1—osteoporosis	1.8e-05	7.41e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—RAP1A—osteoporosis	1.8e-05	7.4e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—LEP—osteoporosis	1.8e-05	7.4e-05	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—PSMA2—osteoporosis	1.79e-05	7.39e-05	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—PSMA5—osteoporosis	1.79e-05	7.39e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling by GPCR—POMC—osteoporosis	1.79e-05	7.37e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—CALCA—osteoporosis	1.78e-05	7.35e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—CALCA—osteoporosis	1.78e-05	7.35e-05	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—IRS2—osteoporosis	1.77e-05	7.31e-05	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—IL6R—osteoporosis	1.77e-05	7.3e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—SPP1—osteoporosis	1.77e-05	7.29e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—SPP1—osteoporosis	1.76e-05	7.25e-05	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—IGF1—osteoporosis	1.75e-05	7.2e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling by GPCR—IL6R—osteoporosis	1.74e-05	7.19e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—ESR1—osteoporosis	1.74e-05	7.16e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—MTHFR—osteoporosis	1.72e-05	7.1e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Metabolism—ADCY5—osteoporosis	1.72e-05	7.08e-05	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—IRS2—osteoporosis	1.72e-05	7.07e-05	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—IRS2—osteoporosis	1.72e-05	7.07e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—ESR1—osteoporosis	1.71e-05	7.07e-05	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—ENO1—osteoporosis	1.71e-05	7.06e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Metabolism—GPX1—osteoporosis	1.71e-05	7.06e-05	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—PSMA2—osteoporosis	1.69e-05	6.96e-05	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—PSMA5—osteoporosis	1.69e-05	6.96e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—KL—osteoporosis	1.67e-05	6.9e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—MTHFR—osteoporosis	1.67e-05	6.86e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—MTHFR—osteoporosis	1.67e-05	6.86e-05	CbGpPWpGaD
Fluphenazine—CALM3—Hemostasis—TGFB1—osteoporosis	1.64e-05	6.76e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—IRS2—osteoporosis	1.64e-05	6.75e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by GPCR—POMC—osteoporosis	1.63e-05	6.73e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—IRS1—osteoporosis	1.62e-05	6.69e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—KL—osteoporosis	1.62e-05	6.67e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—KL—osteoporosis	1.62e-05	6.67e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—ADCY5—osteoporosis	1.6e-05	6.62e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—IRS1—osteoporosis	1.6e-05	6.6e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—IRS2—osteoporosis	1.6e-05	6.59e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by GPCR—IL6R—osteoporosis	1.59e-05	6.56e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—IRS2—osteoporosis	1.59e-05	6.56e-05	CbGpPWpGaD
Fluphenazine—CALM2—Hemostasis—TGFB1—osteoporosis	1.59e-05	6.54e-05	CbGpPWpGaD
Fluphenazine—CALM1—Hemostasis—TGFB1—osteoporosis	1.59e-05	6.54e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—IRS2—osteoporosis	1.58e-05	6.53e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—IRS2—osteoporosis	1.58e-05	6.53e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Metabolism—MTHFR—osteoporosis	1.58e-05	6.51e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—ADCY5—osteoporosis	1.58e-05	6.51e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by GPCR—POMC—osteoporosis	1.58e-05	6.51e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by GPCR—POMC—osteoporosis	1.58e-05	6.51e-05	CbGpPWpGaD
Fluphenazine—CYP2E1—Metabolism—ADCY5—osteoporosis	1.58e-05	6.5e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—ADCY5—osteoporosis	1.58e-05	6.5e-05	CbGpPWpGaD
Fluphenazine—CYP2E1—Metabolism—GPX1—osteoporosis	1.57e-05	6.48e-05	CbGpPWpGaD
Fluphenazine—CALM3—Metabolism—ADCY5—osteoporosis	1.57e-05	6.46e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.57e-05	6.46e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—LEP—osteoporosis	1.57e-05	6.45e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—POMC—osteoporosis	1.56e-05	6.44e-05	CbGpPWpGaD
Fluphenazine—CALM3—Metabolism—GPX1—osteoporosis	1.56e-05	6.44e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—LEP—osteoporosis	1.56e-05	6.42e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—SPP1—osteoporosis	1.55e-05	6.4e-05	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—IRS1—osteoporosis	1.55e-05	6.38e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—POMC—osteoporosis	1.54e-05	6.36e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by GPCR—IL6R—osteoporosis	1.54e-05	6.35e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by GPCR—IL6R—osteoporosis	1.54e-05	6.35e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—SPP1—osteoporosis	1.53e-05	6.3e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—IL6R—osteoporosis	1.53e-05	6.29e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—SPP1—osteoporosis	1.52e-05	6.28e-05	CbGpPWpGaD
Fluphenazine—CALM1—Metabolism—ADCY5—osteoporosis	1.52e-05	6.25e-05	CbGpPWpGaD
Fluphenazine—CALM2—Metabolism—ADCY5—osteoporosis	1.52e-05	6.25e-05	CbGpPWpGaD
Fluphenazine—CALM2—Metabolism—GPX1—osteoporosis	1.51e-05	6.23e-05	CbGpPWpGaD
Fluphenazine—CALM1—Metabolism—GPX1—osteoporosis	1.51e-05	6.23e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—IL6R—osteoporosis	1.5e-05	6.2e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—IGF1—osteoporosis	1.5e-05	6.2e-05	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—IRS1—osteoporosis	1.5e-05	6.17e-05	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—IRS1—osteoporosis	1.5e-05	6.17e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—ESR1—osteoporosis	1.49e-05	6.16e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—ESR1—osteoporosis	1.49e-05	6.13e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—IGF1—osteoporosis	1.48e-05	6.12e-05	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—IL6R—osteoporosis	1.45e-05	6e-05	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—CYP19A1—osteoporosis	1.45e-05	5.99e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—ENO1—osteoporosis	1.45e-05	5.99e-05	CbGpPWpGaD
Fluphenazine—CYP2E1—Metabolism—MTHFR—osteoporosis	1.45e-05	5.98e-05	CbGpPWpGaD
Fluphenazine—CALM3—Metabolism—MTHFR—osteoporosis	1.44e-05	5.94e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—ADCY5—osteoporosis	1.44e-05	5.92e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—PSMA2—osteoporosis	1.43e-05	5.9e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—PSMA5—osteoporosis	1.43e-05	5.9e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—IRS1—osteoporosis	1.43e-05	5.89e-05	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—IL6R—osteoporosis	1.41e-05	5.8e-05	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—IL6R—osteoporosis	1.41e-05	5.8e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—IRS2—osteoporosis	1.4e-05	5.79e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—IRS1—osteoporosis	1.4e-05	5.75e-05	CbGpPWpGaD
Fluphenazine—CALM1—Metabolism—MTHFR—osteoporosis	1.39e-05	5.75e-05	CbGpPWpGaD
Fluphenazine—CALM2—Metabolism—MTHFR—osteoporosis	1.39e-05	5.75e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—SPP1—osteoporosis	1.39e-05	5.73e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—IRS1—osteoporosis	1.39e-05	5.73e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—IRS1—osteoporosis	1.38e-05	5.7e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—IRS1—osteoporosis	1.38e-05	5.7e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—IRS2—osteoporosis	1.38e-05	5.69e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—IRS2—osteoporosis	1.38e-05	5.68e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—LEP—osteoporosis	1.37e-05	5.66e-05	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—CYP19A1—osteoporosis	1.37e-05	5.65e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—LEP—osteoporosis	1.35e-05	5.57e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—LEP—osteoporosis	1.35e-05	5.56e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—POMC—osteoporosis	1.34e-05	5.54e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—IL6R—osteoporosis	1.34e-05	5.54e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—POMC—osteoporosis	1.34e-05	5.51e-05	CbGpPWpGaD
Fluphenazine—HTR6—Signaling by GPCR—IL6—osteoporosis	1.34e-05	5.51e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—ESR1—osteoporosis	1.31e-05	5.41e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—IL6R—osteoporosis	1.31e-05	5.41e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—ADCY5—osteoporosis	1.31e-05	5.4e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—IL6R—osteoporosis	1.3e-05	5.38e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—IL6R—osteoporosis	1.3e-05	5.36e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—IL6R—osteoporosis	1.3e-05	5.36e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—IGF1—osteoporosis	1.29e-05	5.33e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—ESR1—osteoporosis	1.29e-05	5.32e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—ESR1—osteoporosis	1.29e-05	5.31e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—IGF1—osteoporosis	1.29e-05	5.3e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—SPP1—osteoporosis	1.27e-05	5.23e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—ADCY5—osteoporosis	1.27e-05	5.23e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—ADCY5—osteoporosis	1.27e-05	5.23e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Metabolism—POMC—osteoporosis	1.26e-05	5.21e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—IRS2—osteoporosis	1.26e-05	5.18e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—LEP—osteoporosis	1.23e-05	5.07e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—SPP1—osteoporosis	1.23e-05	5.06e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—SPP1—osteoporosis	1.23e-05	5.06e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—IRS1—osteoporosis	1.23e-05	5.05e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—IRS1—osteoporosis	1.21e-05	4.97e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—IRS1—osteoporosis	1.2e-05	4.96e-05	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—ADCY5—osteoporosis	1.19e-05	4.9e-05	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—GPX1—osteoporosis	1.18e-05	4.88e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—POMC—osteoporosis	1.18e-05	4.87e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—ESR1—osteoporosis	1.17e-05	4.84e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—POMC—osteoporosis	1.16e-05	4.79e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—CYP19A1—osteoporosis	1.16e-05	4.78e-05	CbGpPWpGaD
Fluphenazine—CYP2E1—Metabolism—POMC—osteoporosis	1.16e-05	4.78e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—POMC—osteoporosis	1.16e-05	4.78e-05	CbGpPWpGaD
Fluphenazine—CALM3—Metabolism—POMC—osteoporosis	1.15e-05	4.75e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—IL6R—osteoporosis	1.15e-05	4.75e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling by GPCR—IL6—osteoporosis	1.15e-05	4.74e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—IRS2—osteoporosis	1.15e-05	4.73e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—IGF1—osteoporosis	1.14e-05	4.68e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling by GPCR—IL6—osteoporosis	1.13e-05	4.68e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—IL6R—osteoporosis	1.13e-05	4.67e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—IL6R—osteoporosis	1.13e-05	4.66e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—LEP—osteoporosis	1.12e-05	4.63e-05	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—ADCY5—osteoporosis	1.12e-05	4.61e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—IGF1—osteoporosis	1.12e-05	4.61e-05	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—GPX1—osteoporosis	1.12e-05	4.6e-05	CbGpPWpGaD
Fluphenazine—CALM2—Metabolism—POMC—osteoporosis	1.12e-05	4.6e-05	CbGpPWpGaD
Fluphenazine—CALM1—Metabolism—POMC—osteoporosis	1.12e-05	4.6e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—IGF1—osteoporosis	1.11e-05	4.6e-05	CbGpPWpGaD
Fluphenazine—CALM3—Innate Immune System—IL6—osteoporosis	1.11e-05	4.59e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—IRS2—osteoporosis	1.11e-05	4.57e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—IRS2—osteoporosis	1.11e-05	4.57e-05	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—IL1B—osteoporosis	1.11e-05	4.56e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—IRS1—osteoporosis	1.1e-05	4.52e-05	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—MTHFR—osteoporosis	1.09e-05	4.5e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—LEP—osteoporosis	1.09e-05	4.48e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—LEP—osteoporosis	1.09e-05	4.48e-05	CbGpPWpGaD
Fluphenazine—CALM1—Innate Immune System—IL6—osteoporosis	1.08e-05	4.44e-05	CbGpPWpGaD
Fluphenazine—CALM2—Innate Immune System—IL6—osteoporosis	1.08e-05	4.44e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—ESR1—osteoporosis	1.07e-05	4.42e-05	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—IL1B—osteoporosis	1.07e-05	4.41e-05	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—IL1B—osteoporosis	1.07e-05	4.41e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—POMC—osteoporosis	1.06e-05	4.36e-05	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—MYC—osteoporosis	1.05e-05	4.33e-05	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—TGFB1—osteoporosis	1.05e-05	4.32e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—ESR1—osteoporosis	1.04e-05	4.27e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—ESR1—osteoporosis	1.04e-05	4.27e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—IL6R—osteoporosis	1.03e-05	4.25e-05	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—MTHFR—osteoporosis	1.03e-05	4.24e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—IGF1—osteoporosis	1.02e-05	4.19e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—IRS1—osteoporosis	1e-05	4.13e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling by GPCR—IL6—osteoporosis	9.89e-06	4.08e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling by GPCR—IL6—osteoporosis	9.84e-06	4.06e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—IRS1—osteoporosis	9.69e-06	3.99e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—IRS1—osteoporosis	9.69e-06	3.99e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—POMC—osteoporosis	9.64e-06	3.97e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—ADCY5—osteoporosis	9.48e-06	3.91e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—GPX1—osteoporosis	9.45e-06	3.9e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—IL6R—osteoporosis	9.41e-06	3.88e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—POMC—osteoporosis	9.33e-06	3.84e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—POMC—osteoporosis	9.33e-06	3.84e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—IGF1—osteoporosis	9.27e-06	3.82e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—IL6R—osteoporosis	9.1e-06	3.75e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—IL6R—osteoporosis	9.1e-06	3.75e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—MYC—osteoporosis	9.04e-06	3.73e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—TGFB1—osteoporosis	9.02e-06	3.72e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—IGF1—osteoporosis	8.97e-06	3.7e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—IGF1—osteoporosis	8.97e-06	3.7e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—MYC—osteoporosis	8.92e-06	3.68e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—TGFB1—osteoporosis	8.9e-06	3.67e-05	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—POMC—osteoporosis	8.74e-06	3.6e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—MTHFR—osteoporosis	8.72e-06	3.6e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling by GPCR—IL6—osteoporosis	8.68e-06	3.58e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling by GPCR—IL6—osteoporosis	8.54e-06	3.52e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling by GPCR—IL6—osteoporosis	8.53e-06	3.51e-05	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—POMC—osteoporosis	8.23e-06	3.39e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—MYC—osteoporosis	7.96e-06	3.28e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—TGFB1—osteoporosis	7.94e-06	3.27e-05	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—IL6—osteoporosis	7.89e-06	3.25e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling by GPCR—IL6—osteoporosis	7.77e-06	3.2e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—MYC—osteoporosis	7.77e-06	3.2e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—TGFB1—osteoporosis	7.75e-06	3.2e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—MYC—osteoporosis	7.73e-06	3.19e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—TGFB1—osteoporosis	7.71e-06	3.18e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—MYC—osteoporosis	7.7e-06	3.17e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—MYC—osteoporosis	7.7e-06	3.17e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—TGFB1—osteoporosis	7.68e-06	3.17e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—TGFB1—osteoporosis	7.68e-06	3.17e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by GPCR—IL6—osteoporosis	7.09e-06	2.92e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—POMC—osteoporosis	6.98e-06	2.88e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by GPCR—IL6—osteoporosis	6.86e-06	2.83e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by GPCR—IL6—osteoporosis	6.86e-06	2.83e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—MYC—osteoporosis	6.82e-06	2.81e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—TGFB1—osteoporosis	6.81e-06	2.81e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—IL6—osteoporosis	6.79e-06	2.8e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—MYC—osteoporosis	6.71e-06	2.77e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—IL6—osteoporosis	6.7e-06	2.76e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—MYC—osteoporosis	6.7e-06	2.76e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—TGFB1—osteoporosis	6.7e-06	2.76e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—TGFB1—osteoporosis	6.68e-06	2.75e-05	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—IL6—osteoporosis	6.48e-06	2.67e-05	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—IL6—osteoporosis	6.27e-06	2.58e-05	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—IL6—osteoporosis	6.27e-06	2.58e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—MYC—osteoporosis	6.11e-06	2.52e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—TGFB1—osteoporosis	6.09e-06	2.51e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—IL6—osteoporosis	5.98e-06	2.47e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—IL6—osteoporosis	5.84e-06	2.41e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—IL6—osteoporosis	5.81e-06	2.4e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—IL6—osteoporosis	5.79e-06	2.39e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—IL6—osteoporosis	5.79e-06	2.39e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—MYC—osteoporosis	5.57e-06	2.3e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—TGFB1—osteoporosis	5.56e-06	2.29e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—MYC—osteoporosis	5.39e-06	2.22e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—MYC—osteoporosis	5.39e-06	2.22e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—TGFB1—osteoporosis	5.38e-06	2.22e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—TGFB1—osteoporosis	5.38e-06	2.22e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—IL6—osteoporosis	5.13e-06	2.11e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—IL6—osteoporosis	5.05e-06	2.08e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—IL6—osteoporosis	5.04e-06	2.08e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—IL6—osteoporosis	4.59e-06	1.89e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—IL6—osteoporosis	4.19e-06	1.73e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—IL6—osteoporosis	4.05e-06	1.67e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—IL6—osteoporosis	4.05e-06	1.67e-05	CbGpPWpGaD
